1 |
Bucher K, Rodríguez-Bocanegra E, Wissinger B, Strasser T, Clark SJ, Birkenfeld AL, Siegel-Axel D, Fischer MD. Extra-viral DNA in adeno-associated viral vector preparations induces TLR9-dependent innate immune responses in human plasmacytoid dendritic cells. Sci Rep 2023;13:1890. [PMID: 36732401 DOI: 10.1038/s41598-023-28830-7] [Reference Citation Analysis]
|
2 |
Huang X, Wang X, Ren Y, Gao P, Xu W, Xie X, Diao Y. Reactive oxygen species enhance rAAV transduction by promoting its escape from late endosomes. Virol J 2023;20:2. [PMID: 36611172 DOI: 10.1186/s12985-023-01964-w] [Reference Citation Analysis]
|
3 |
Xie YL, Wang JY, He Y, Yu XM, Zheng QY, Ling C, Feng XL, Zhu LQ. The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo. J Integr Med 2023;21:106-15. [PMID: 36333178 DOI: 10.1016/j.joim.2022.10.003] [Reference Citation Analysis]
|
4 |
Patel DD, Marsic D, Periasamy R, Zolotukhin S, Lipinski DM. Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution. Transl Vis Sci Technol 2022;11:28. [PMID: 36018583 DOI: 10.1167/tvst.11.8.28] [Reference Citation Analysis]
|
5 |
Peng Z, Lu H, Yang Q, Xie Q. Astrocyte Reprogramming in Stroke: Opportunities and Challenges. Front Aging Neurosci 2022;14:885707. [DOI: 10.3389/fnagi.2022.885707] [Reference Citation Analysis]
|
6 |
Bucher K, Rodriguez-Bocanegra E, Fischer MD. Benefits and Shortcomings of Laboratory Model Systems in the Development of Genetic Therapies. Klin Monbl Augenheilkd 2022;239:263-9. [PMID: 35316853 DOI: 10.1055/a-1757-9879] [Reference Citation Analysis]
|
7 |
Macdonald J, Marx J, Büning H. Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors. Hum Gene Ther 2021;32:1096-119. [PMID: 34662226 DOI: 10.1089/hum.2021.169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
8 |
Ran G, Feng XL, Xie YL, Zheng QY, Guo PP, Yang M, Feng YL, Ling C, Zhu LQ, Zhong C. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. J Integr Med 2021;19:515-25. [PMID: 34538767 DOI: 10.1016/j.joim.2021.09.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
9 |
Zheng Q, Wang T, Zhu X, Tian X, Zhong C, Chang G, Ran G, Xie Y, Zhao B, Zhu L, Ling C. Low endotoxin E. coli strain-derived plasmids reduce rAAV vector-mediated immune responses both in vitro and in vivo. Mol Ther Methods Clin Dev 2021;22:293-303. [PMID: 34485612 DOI: 10.1016/j.omtm.2021.06.009] [Reference Citation Analysis]
|
10 |
Colón-Thillet R, Jerome KR, Stone D. Optimization of AAV vectors to target persistent viral reservoirs. Virol J 2021;18:85. [PMID: 33892762 DOI: 10.1186/s12985-021-01555-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
11 |
Rodríguez-Márquez E, Meumann N, Büning H. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy. Expert Opin Biol Ther 2021;21:749-66. [PMID: 33331201 DOI: 10.1080/14712598.2021.1865303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
12 |
Biswas M, Marsic D, Li N, Zou C, Gonzalez-Aseguinolaza G, Zolotukhin I, Kumar SRP, Rana J, Butterfield JSS, Kondratov O, de Jong YP, Herzog RW, Zolotukhin S. Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity. Mol Ther Methods Clin Dev 2020;19:347-61. [PMID: 33145371 DOI: 10.1016/j.omtm.2020.09.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
13 |
Rambhai HK, Ashby FJ 3rd, Qing K, Srivastava A. Role of Essential Metal Ions in AAV Vector-Mediated Transduction. Mol Ther Methods Clin Dev 2020;18:159-66. [PMID: 32637447 DOI: 10.1016/j.omtm.2020.05.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|